Clinical Trials Directory

Trials / Terminated

TerminatedNCT01326390

Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma

Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma

Status
Terminated
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.

Conditions

Interventions

TypeNameDescription
DEVICEdTA/dBA C-arm fluoroscopy system with Dyna CTC-arm CT of the liver; state-of-the-art flat panel detector on a ceiling or floor mounted C-arm gantry
PROCEDUREDSA arteriogram- hepatic arteriesStandard of care
PROCEDURECO2 aortogramStandard of care

Timeline

Start date
2010-05-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2011-03-30
Last updated
2016-07-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01326390. Inclusion in this directory is not an endorsement.